Amanda Psyrri
ScholarGPS® ID: 56132451905868
Affiliation History
Field
Medicine
Discipline
Oncology
Top Specialties
Cancer | Squamous Cell Carcinoma | Neoplasm | Breast Cancer | Human Papillomavirus Infection | Chemotherapy | Metastatic Breast Cancer | Immunotherapy | Ovarian Cancer | Cisplatin | Colorectal Cancer | Mutation | Lung Cancer | Lymphoma | Trastuzumab
Metrics Summary
Publication Count
324
Predicted Citations
12,471
Predicted h-index
61
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Evasion of apoptosis and treatment resistance in squamous cell carcinoma of the head and neck (journal article) Cancer Treatment Reviews, volume 129 (2024). |
The Lancet Oncology, volume 25, issue 7, pages e318-e330 (2024). |
Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 6088-6088 (2024). |
Journal of Clinical Oncology, volume 42, issue 16_suppl, pages e23529-e23529 (2024). |
Overcoming Resistance to Temozolomide in Glioblastoma: A Scoping Review of Preclinical and Clinical Data (journal article) Life, volume 14, issue 6, pages 673- (2024). |
An algorithm for standardization of tumor Infiltrating lymphocyte evaluation in head and neck cancers (journal article) Oral Oncology, volume 152 (2024). |
Detection of hotspot PIK3CA mutations in primary tumors and plasma-cfDNA of breast cancer patients using a novel highly sensitive CE-IVD KIT (journal article) Clinica Chimica Acta, volume 558 (2024). |
Clinica Chimica Acta, volume 558 (2024). |
Human Papilloma Virus (HPV) driven oropharyngeal cancer in current or previous heavy smokers: should we look for a different treatment paradigm? (journal article) Frontiers in Oncology, volume 14 (2024). |
Is osimertinib effective as 2nd line treatment in T790M-negative EGFR mutant NSCLC? (journal article) AME Clinical Trials Review, volume 2 (2024). |
Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma (journal article) Cancer Immunology, Immunotherapy, volume 73, issue 4 (2024). |
Immuno-Oncology and Technology, volume 20 (2023). |
Immuno-Oncology and Technology, volume 20 (2023). |
Immune checkpoint inhibitors in sarcomas: a systematic review (journal article) Immuno-Oncology and Technology, volume 20 (2023). |
Annals of Oncology, volume 34 (2023). |
Prolonged impact of anti-cancer therapy on endothelial function and arterial stiffness in breast cancer patients (journal article) Vascular Pharmacology, volume 152 (2023). |
Human Papillomavirus 16 DNA Methylation Patterns and Investigation of Integration Status in Head and Neck Cancer Cases (journal article) International Journal of Molecular Sciences, volume 24, issue 19, pages 14593- (2023). |
Current Oncology, volume 30, issue 8, pages 7608-7619 (2023). |
Clinical Significance of PD-L1 Status in Circulating Tumor Cells for Cancer Management during Immunotherapy (journal article) Biomedicines, volume 11, issue 6, pages 1768- (2023). |